1. Home
  2. DCBO vs SGHT Comparison

DCBO vs SGHT Comparison

Compare DCBO & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Docebo Inc.

DCBO

Docebo Inc.

N/A

Current Price

$28.89

Market Cap

582.0M

Sector

N/A

ML Signal

N/A

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

N/A

Current Price

$10.05

Market Cap

489.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DCBO
SGHT
Founded
2016
2011
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
582.0M
489.7M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
DCBO
SGHT
Price
$28.89
$10.05
Analyst Decision
Buy
Buy
Analyst Count
11
8
Target Price
★ $30.93
$10.17
AVG Volume (30 Days)
36.5K
★ 294.6K
Earning Date
11-06-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 28.16
EPS
★ N/A
N/A
Revenue
N/A
★ $77,363,000.00
Revenue This Year
$13.54
$16.75
Revenue Next Year
$10.07
$11.78
P/E Ratio
$22.04
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$14.39
$3.38
52 Week High
$31.27
$10.06

Technical Indicators

Market Signals
Indicator
DCBO
SGHT
Relative Strength Index (RSI) 64.13 66.28
Support Level $16.54 $7.88
Resistance Level $31.27 N/A
Average True Range (ATR) 1.27 0.56
MACD -0.11 0.08
Stochastic Oscillator 52.56 83.07

Price Performance

Historical Comparison
DCBO
SGHT

About DCBO Docebo Inc.

Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: